More recently, it has been discovered that the NO-dependent EGFR activation can induce Extracellular signal-Regulated Kinase (ERK) phosphorylation—whose abnormal elevation has been described in tumor cells—thus activating it in basal-like triple negative breast cancer (50). This evidence concerns the gene MAPK1 and neoplasm.